Cargando…
Is Mitochondrial Oxidative Stress a Viable Therapeutic Target in Preeclampsia?
Despite considerable research efforts over the past few decades, the pathology of preeclampsia (PE) remains poorly understood with no new FDA-approved treatments. There is a substantial amount of work being conducted by investigators around the world to identify targets to develop therapies for PE....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868187/ https://www.ncbi.nlm.nih.gov/pubmed/35204094 http://dx.doi.org/10.3390/antiox11020210 |